Tritoqualine
From Wikipedia, the free encyclopedia
 |
|
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | R06AX21 (WHO) |
| Identifiers | |
|
|
| CAS Number | 14504-73-5 |
| PubChem (CID) | 72145 |
| ChemSpider | 65119 |
| UNII | F4MW5166YH  |
| Chemical and physical data | |
| Formula | C26H32N2O8 |
| Molar mass | 500.54 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
Tritoqualine, also known as hypostamine, is an inhibitor of the enzyme histidine decarboxylase and therefore an atypical antihistamine, used for the treatment of urticaria and allergic rhinitis[1] with no known adverse effects.[citation needed]
References[edit]
- ^ Randomized, placebo controlled study of tritoqualine (hypostamine*) in the treatment of perennial allergic rhinitis. A. Pradalier, V. Hentschel, S. Prouzeau, D. Legallais, G. Lefrançois. Revue Française d’Allergologie et d’Immunologie Clinique 43:175-179 (2003)
 |
This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
